Life Sciences compliance news

Browse by Tags

• Intel Wins FDA Approval for In-Home Medical Device (Update1)

  July 10 (Bloomberg) -- Intel Corp., the world's largest chipmaker, won U.S. Food and Drug Administration clearance to begin selling a medical computer designed to help the elderly manage health conditions at home. Read More... Posted Jul 10 2008, 03:12 PM by CyberWatcher Newsfeed - Life Sciences News Filed under: Bloomberg

• Intel Wins FDA Approval for In-Home Medical Device for Elderly

  July 10 (Bloomberg) -- Intel Corp., the world's largest chipmaker, won U.S. Food and Drug Administration clearance to begin selling a medical computer designed to help the elderly manage health conditions at home. Read More... Posted Jul 10 2008, 01:11 PM by CyberWatcher Newsfeed - Life Sciences News Filed under: Bloomberg

• Otsuka Say FDA Panel Backs Drug to Treat Low Salt in the Blood

  June 25 (Bloomberg) -- Otsuka Pharmaceutical Co. said a U.S. advisory panel backed approval of tolvaptan, the Japanese company's treatment for low concentrations of sodium in the blood. Read More... Posted Jun 25 2008, 11:52 PM by CyberWatcher Newsfeed - Life Sciences News Filed under: Bloomberg

• Bristol, Takeda Drugs Offer Alternatives to Januvia (Update2)

  June 7 (Bloomberg) -- Bristol-Myers Squibb Co., AstraZeneca Plc and Takeda Pharmaceuticals Co.'s experimental diabetes drugs may give U.S. patients effective alternatives to Merck & Co.'s Januvia, one of the newest pills approved for the condition... Posted Jun 07 2008, 10:05 PM by CyberWatcher Newsfeed - Life Sciences News Filed under: Bloomberg

• Bristol, Takeda Drugs Offer Alternatives to Januvia (Correct)

  June 7 (Bloomberg) -- Bristol-Myers Squibb Co., AstraZeneca Plc and Takeda Pharmaceuticals Co.'s experimental diabetes drugs may give U.S. patients effective alternatives to Merck & Co.'s Januvia, one of the newest pills approved for the condition... Posted Jun 07 2008, 09:19 PM by CyberWatcher Newsfeed - Life Sciences News Filed under: Bloomberg

• Bristol, Takeda Drugs Offer Alternatives to Januvia (Update1)

  June 7 (Bloomberg) -- Bristol-Myers Squibb Co., AstraZeneca Plc and Takeda Pharmaceuticals Co.'s experimental diabetes drugs may give U.S. patients effective alternatives to Merck & Co.'s Januvia, one of the newest pills approved for the condition... Posted Jun 07 2008, 07:18 PM by CyberWatcher Newsfeed - Life Sciences News Filed under: Bloomberg

• Bristol, Takeda Drugs Offer Alternatives to Merck's Januvia

  June 7 (Bloomberg) -- Bristol-Myers Squibb Co., AstraZeneca Plc and Takeda Pharmaceuticals Co.'s experimental diabetes drugs may give U.S. patients effective alternatives to Merck & Co.'s Januvia, one of the newest pills approved for the condition... Posted Jun 07 2008, 06:19 PM by CyberWatcher Newsfeed - Life Sciences News Filed under: Bloomberg

• Heparin in Medical Devices Linked to 11 US Deaths (Update3)

  US Recall News (press release) Heparin in Medical Devices Linked to 11 US Deaths (Update3) Bloomberg - 4 hours ago By Justin Blum June 5 (Bloomberg) -- Eleven deaths and 86 cases of harmful side effects this year have been linked to use of medical devices... Posted Jun 06 2008, 01:37 AM by CyberWatcher Newsfeed - Life Sciences News Filed under: Bloomberg

• Heparin in Medical Devices Linked to 11 U.S. Deaths (Update2)

  June 5 (Bloomberg) -- Eleven deaths and 86 cases of harmful side effects this year have been linked to use of medical devices containing the blood thinner heparin, U.S. regulators said. Read More... Posted Jun 05 2008, 06:03 PM by CyberWatcher Newsfeed - Life Sciences News Filed under: Bloomberg

• Heparin in Medical Devices Linked to 11 U.S. Deaths (Update1)

  June 5 (Bloomberg) -- Eleven deaths and 86 cases of harmful side effects have been linked to use of medical devices containing the blood thinner heparin, U.S. regulators said. Read More... Posted Jun 05 2008, 03:48 PM by CyberWatcher Newsfeed - Life Sciences News Filed under: Bloomberg